167 related articles for article (PubMed ID: 22650237)
1. Pharmaceutical structure montages as catalysts for design and discovery.
Njarðarson JT
Future Med Chem; 2012 May; 4(8):951-4. PubMed ID: 22650237
[TBL] [Abstract][Full Text] [Related]
2. Data-mining for sulfur and fluorine: an evaluation of pharmaceuticals to reveal opportunities for drug design and discovery.
Ilardi EA; Vitaku E; Njardarson JT
J Med Chem; 2014 Apr; 57(7):2832-42. PubMed ID: 24102067
[TBL] [Abstract][Full Text] [Related]
3. Structure-based repurposing of FDA-approved drugs as TNF-α inhibitors.
Leung CH; Chan DS; Kwan MH; Cheng Z; Wong CY; Zhu GY; Fong WF; Ma DL
ChemMedChem; 2011 May; 6(5):765-8. PubMed ID: 21365767
[No Abstract] [Full Text] [Related]
4. 970 million druglike small molecules for virtual screening in the chemical universe database GDB-13.
Blum LC; Reymond JL
J Am Chem Soc; 2009 Jul; 131(25):8732-3. PubMed ID: 19505099
[TBL] [Abstract][Full Text] [Related]
5. Drugs in action.
Eggert US; Superti-Furga G
Nat Chem Biol; 2008 Jan; 4(1):7-11. PubMed ID: 18084271
[No Abstract] [Full Text] [Related]
6. Strategies for the use of mixture-based synthetic combinatorial libraries: scaffold ranking, direct testing in vivo, and enhanced deconvolution by computational methods.
Houghten RA; Pinilla C; Giulianotti MA; Appel JR; Dooley CT; Nefzi A; Ostresh JM; Yu Y; Maggiora GM; Medina-Franco JL; Brunner D; Schneider J
J Comb Chem; 2008; 10(1):3-19. PubMed ID: 18067268
[No Abstract] [Full Text] [Related]
7. Natural products as leads to potential drugs: an old process or the new hope for drug discovery?
Newman DJ
J Med Chem; 2008 May; 51(9):2589-99. PubMed ID: 18393402
[No Abstract] [Full Text] [Related]
8. Comprehensive survey of chemical libraries for drug discovery and chemical biology: 2006.
Dolle RE; Le Bourdonnec B; Goodman AJ; Morales GA; Salvino JM; Zhang W
J Comb Chem; 2007; 9(6):855-902. PubMed ID: 17877417
[No Abstract] [Full Text] [Related]
9. The Pharmaceutical Industry in 2016. An Analysis of FDA Drug Approvals from a Perspective of the Molecule Type.
Torre BG; Albericio F
Molecules; 2017 Feb; 22(3):. PubMed ID: 28264468
[TBL] [Abstract][Full Text] [Related]
10. Structural alert/reactive metabolite concept as applied in medicinal chemistry to mitigate the risk of idiosyncratic drug toxicity: a perspective based on the critical examination of trends in the top 200 drugs marketed in the United States.
Stepan AF; Walker DP; Bauman J; Price DA; Baillie TA; Kalgutkar AS; Aleo MD
Chem Res Toxicol; 2011 Sep; 24(9):1345-410. PubMed ID: 21702456
[TBL] [Abstract][Full Text] [Related]
11. Crystallographic fragment screening.
Badger J
Methods Mol Biol; 2012; 841():161-77. PubMed ID: 22222452
[TBL] [Abstract][Full Text] [Related]
12. Druggable pockets and binding site centric chemical space: a paradigm shift in drug discovery.
Pérot S; Sperandio O; Miteva MA; Camproux AC; Villoutreix BO
Drug Discov Today; 2010 Aug; 15(15-16):656-67. PubMed ID: 20685398
[TBL] [Abstract][Full Text] [Related]
13. Recent drug approvals from the US FDA and EMEA: what the future holds.
Pevarello P
Future Med Chem; 2009 Apr; 1(1):35-48. PubMed ID: 21426069
[TBL] [Abstract][Full Text] [Related]
14. Learning from PAINful lessons.
Erlanson DA
J Med Chem; 2015 Mar; 58(5):2088-90. PubMed ID: 25710486
[TBL] [Abstract][Full Text] [Related]
15. Developing a drug-like natural product library.
Quinn RJ; Carroll AR; Pham NB; Baron P; Palframan ME; Suraweera L; Pierens GK; Muresan S
J Nat Prod; 2008 Mar; 71(3):464-8. PubMed ID: 18257534
[TBL] [Abstract][Full Text] [Related]
16. Graph mining: procedure, application to drug discovery and recent advances.
Takigawa I; Mamitsuka H
Drug Discov Today; 2013 Jan; 18(1-2):50-7. PubMed ID: 22889967
[TBL] [Abstract][Full Text] [Related]
17. 'Metabolite-likeness' as a criterion in the design and selection of pharmaceutical drug libraries.
Dobson PD; Patel Y; Kell DB
Drug Discov Today; 2009 Jan; 14(1-2):31-40. PubMed ID: 19049901
[TBL] [Abstract][Full Text] [Related]
18. Is computer-assisted rescaffolding the future in lead generation?
Hessler G; Baringhaus KH
Future Med Chem; 2013 Mar; 5(3):237-9. PubMed ID: 23464513
[No Abstract] [Full Text] [Related]
19. Accelerating the drug-discovery process: new tools and technologies available to medicinal chemists.
Raveglia LF; Giardina GA
Future Med Chem; 2009 Sep; 1(6):1019-23. PubMed ID: 21425990
[No Abstract] [Full Text] [Related]
20. Using novel descriptor accounting for ligand-receptor interactions to define and visually explore biologically relevant chemical space.
Rabal O; Oyarzabal J
J Chem Inf Model; 2012 May; 52(5):1086-102. PubMed ID: 22486368
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
